AAS
ATRS

Avantax Advisory Services’s Antares Pharma, Inc. ATRS Stock Holding History

Avantax Advisory Services’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,500
Closed -$42K – 1393
2020
Q3 		$42K Buy
15,500
+500
+3% +$1.38K ﹤0.01% 1340
2020
Q2 		$41K Hold
15,000
– – ﹤0.01% 838
2020
Q1 		$35K Buy
+15,000
New +$51K ﹤0.01% 782

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Avantax Advisory Services's ATRS Position: Q4 2020 in Review

Avantax Advisory Services sold out of Antares Pharma, Inc. (ATRS) in Q4 2020, closing a stake of 15,500 shares — an estimated $42K sold.

Avantax Advisory Services first reported a position in ATRS in Q1 2020 and held it in 3 quarters. The position peaked at $42K in Q3 2020. 174 funds tracked by Wall St. Rank hold ATRS as of Q4 2020.

  • Avantax Advisory Services reported no remaining Antares Pharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Avantax Advisory Services sold 15,500 Antares Pharma, Inc. shares in Q4 2020, an estimated $42K.
  • Avantax Advisory Services first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 3 quarters.
  • Avantax Advisory Services's Antares Pharma, Inc. position peaked at $42K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2020.

Based on Avantax Advisory Services's 13F filing for Q4 2020, filed 22 Jan 2021.